Monday, 17 January 2022

BUY Simigon & The 13p Valuation 17/01/2022

 Yes , sometimes It is possible to be sitting on a just released RNS which the Market , seems to be in denial of .

This BOD have continually struggled to make headway with cash being too tight , even with a relatively good product , sometimes profits are a hard won creature .

Those whom deal in shares will understand the fragility of immediate profits .

Currently 6p and , soon to be 13p . Whence March comes this should be a no-brainer .

But , Every share decision has It`s risks , as with every decision in life .

March time to delist , then May plus to return as Maxify on the Nasdaq seems specific enough for me .

I am IN .

Outstanding RNS 

No comments:

Post a Comment